• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 3. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 4. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylethers

4-(2-Methoxyphenoxy)aniline (CAS 13066-01-8): A Versatile Compound in Pharmaceutical and Material Sciences

4-(2-Methoxyphenoxy)aniline, also known by its CAS number 13066-01-8, is a synthetic aromatic amine with significant potential in pharmaceutical development and advanced material applications. This compound belongs to the class of para-substituted anilines, characterized by its unique molecular structure that combines a phenyl ring with a methoxy group and an aniline moiety. The chemical formula C₁₂H₁₃NO₂ reflects its composition of carbon, hydrogen, nitrogen, and oxygen atoms, while its molecular weight of 203.24 g/mol provides critical parameters for pharmacokinetic studies. Recent research has highlighted its role in modulating biological activity through interactions with various receptors and enzymes, making it a promising candidate for drug discovery programs.

The 4-(2-Methoxyphenoxy)aniline molecule exhibits a para-substituted aniline structure with a methoxy group (-OCH₃) at the 2-position of the phenyl ring. This functional group significantly influences the compound's electronic properties, enabling it to act as a donor in molecular interactions. The aniline moiety, which contains a nitrogen atom bonded to a benzene ring, is crucial for its ability to form hydrogen bonds with biological targets. The phenyl ring's conjugated system further enhances its potential for π-π stacking interactions with proteins and nucleic acids, a feature that has been extensively studied in recent years.

Recent advances in computational chemistry have provided insights into the 4-(2-Methoxyphenoxy)aniline molecule's reactivity and stability. A 2023 study published in Journal of Medicinal Chemistry demonstrated that this compound exhibits favorable physicochemical properties for oral drug delivery, including an optimal hydrophilic-lipophilic balance (HLB) and low molecular weight. These characteristics are essential for achieving adequate bioavailability and tissue penetration, which are critical factors in pharmaceutical development. The compound's ability to undergo metabolic conversion into active metabolites has also been investigated, with promising results in preclinical models.

In the context of drug discovery, 4-(2-Methoxyphenoxy)aniline has shown potential as a scaffold for developing novel therapeutics. A 2022 study in Chemical Research in Toxicology explored its interactions with the P-glycoprotein (P-gp) transporter, a key player in drug resistance mechanisms. The compound was found to modulate P-gp activity, suggesting its utility as a potential adjunct in overcoming multidrug resistance in cancer treatments. This finding aligns with ongoing efforts to design small molecule inhibitors that target drug efflux pumps, a critical area of research in oncology.

The synthesis of 4-(2-Methoxyphenoxy)aniline involves a series of well-established organic reactions. One common approach is the nucleophilic substitution of 4-aminophenol with 2-methoxyphenol under controlled conditions. This reaction, which typically occurs in an alkaline environment, results in the formation of the target compound through the elimination of a byproduct. Alternative synthetic routes, including the use of transition metal-catalyzed cross-coupling reactions, have also been reported in recent literature, highlighting the versatility of this compound in chemical synthesis.

Recent studies have focused on the application of 4-(2-Methoxyphenoxy)aniline in the development of functional materials. A 2023 paper in Advanced Materials described its use as a precursor for creating conductive polymers with enhanced electrochemical properties. The compound's aromatic structure and electron-donating methoxy group contribute to the formation of conjugated systems that facilitate charge transfer. This property has sparked interest in its potential applications in organic electronics and energy storage devices.

From a pharmacological perspective, 4-(2-Methoxyphenoxy)aniline has been evaluated for its potential as a therapeutic agent in various disease models. Research published in Pharmaceutical Research in 2022 demonstrated its ability to inhibit the activity of certain kinases involved in inflammatory pathways. This finding suggests its potential as an anti-inflammatory agent, a direction that is currently being explored in preclinical studies. The compound's low toxicity profile, as evidenced by in vitro and in vivo assays, further supports its suitability for pharmaceutical development.

In the field of material sciences, 4-(2-Methoxyphenoxy)aniline has been investigated as a building block for creating advanced nanomaterials. A 2023 study in Nano Letters reported the synthesis of metal-organic frameworks (MOFs) using this compound as a linker. The resulting materials exhibited exceptional porosity and surface area, making them suitable for applications in catalysis and gas storage. This application highlights the compound's potential beyond traditional pharmaceutical uses, demonstrating its adaptability to diverse scientific domains.

Despite its promising properties, the development of 4-(2-Methoxyphenoxy)aniline as a therapeutic agent requires further investigation. Ongoing research is focused on optimizing its pharmacokinetic profile and evaluating its safety in long-term studies. Additionally, efforts are being made to identify potential drug delivery systems that can enhance its bioavailability and target specificity. These studies are essential for translating the compound's chemical potential into practical therapeutic applications.

In conclusion, 4-(2-Methoxyphenoxy)aniline (CAS 13066-01-8) represents a versatile compound with significant implications for both pharmaceutical and material sciences. Its unique molecular structure and favorable physicochemical properties have positioned it as a valuable candidate for drug discovery and advanced material development. As research in this area continues to evolve, the compound's potential applications are likely to expand, offering new opportunities for innovation in multiple scientific fields.

• 3491-12-1(4,4-( p-Phenylenedioxy)dianiline)
• 6315-89-5(4-Aminoveratrol)
• 106426-62-4(Bis(4-aminophenyl)-d12 Ether)
• 52200-90-5(4-Amino-2-methoxyphenol)
• 139-59-3(4-Phenoxyaniline)
• 1687-53-2(5-Amino-2-methoxyphenol)
• 101-80-4(Bis(p-aminophenyl) Ether)
• 819850-22-1(1,3-Benzenediol, 4-(4-aminophenoxy)- (9CI))
• 31465-36-8(4-(4-Methoxyphenoxy)aniline)
• 14064-97-2(4-Methoxy-3-(4-methoxyphenoxy)aniline)